🔗 Visit the ClinicalTrials.gov page for NCT01462214
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial watch: Chemotherapy with immunogenic cell death inducers. | Oncoimmunology | 2012 | 1.33 |
| 2 | Targeting CD8+ T-cell tolerance for cancer immunotherapy. | Immunotherapy | 2014 | 0.81 |
| 3 | Phase I-II study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell cancer. | BMC Cancer | 2011 | 0.78 |